Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 1
2004 1
2005 1
2006 1
2007 1
2008 2
2011 4
2012 5
2013 5
2014 4
2015 1
2016 6
2017 7
2018 4
2019 9
2020 6
2021 3
2022 5
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

PubMed for id: 1737970

69 results

Results by year

Filters applied: . Clear all
Page 1
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C. O'Cearbhaill RE, et al. Gynecol Oncol. 2023 Sep;176:16-24. doi: 10.1016/j.ygyno.2023.06.021. Epub 2023 Jul 5. Gynecol Oncol. 2023. PMID: 37418832 Clinical Trial.
SPON1 is an independent prognostic biomarker for ovarian cancer.
Miyakawa R, Kobayashi M, Sugimoto K, Endo Y, Kojima M, Kobayashi Y, Furukawa S, Honda T, Watanabe T, Asano S, Soeda S, Hashimoto Y, Fujimori K, Chiba H. Miyakawa R, et al. J Ovarian Res. 2023 May 13;16(1):95. doi: 10.1186/s13048-023-01180-8. J Ovarian Res. 2023. PMID: 37179355 Free PMC article.
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.
Bourien H, Lefevre LB, Mouret-Reynier MA, Asselain B, Lucas B, Gavoille C, Cornila C, Gavoille L, Colomba E, Patsouris A, Fabbro M, Chakiba C, Toussaint P, Simon H, Berton D, Garbay D, Tixidre CG, Coeffic D, Morvan A, Collard O, DE LA Motte Rouge T. Bourien H, et al. Anticancer Res. 2023 Feb;43(2):653-662. doi: 10.21873/anticanres.16202. Anticancer Res. 2023. PMID: 36697069
Extracellular Matrix Modulates Outgrowth Dynamics in Ovarian Cancer.
Alshehri S, Pavlovič T, Farsinejad S, Behboodi P, Quan L, Centeno D, Kung D, Rezler M, Lee W, Jasiński P, Dziabaszewska E, Nowak-Markwitz E, Kalyon D, Zaborowski MP, Iwanicki M. Alshehri S, et al. Adv Biol (Weinh). 2022 Dec;6(12):e2200197. doi: 10.1002/adbi.202200197. Epub 2022 Sep 9. Adv Biol (Weinh). 2022. PMID: 36084257 Free PMC article.
69 results